跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ciltamin 1.5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ciltamin 1.5
Approved
STANDARD
Ciltamin 1.5
Samjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7fafcc39151491c2
Company
Samjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
7fafcc39151491c2
Drug Approval Philippines Name
Ciltamin 1.5
Product Name
Ciltamin 1.5
Registration Number
DR-XY39040
Brand Name
Ciltamin 1.5
Generic Name
Ampicillin (as Sodium) + Sulbactam (as Sodium)
Dosage Form
Powder For Injection (Im/Iv)
Dosage Strength
1g/500mg
Manufacturer
Samjin Pharmaceutical Co., Ltd.
Importer
Natrapharm, Inc.
Distributor
Natrapharm, Inc.
Company Detail Path
/organization/samjin-pharmaceutical-co-ltd
Issuance Date
02 November 2023
Expiry Date
10 February 2029
Pharmacologic Category
Antibacterial (Penicillin/Beta-lactamase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7fafcc39151491c2
Type
Standard
Back to Philippines FDA Approvals